Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Germinal center responses to SARS-CoV-2 mRNA vaccines in healthy and immunocompromised individuals
Katlyn Lederer, Emily Bettini, Kalpana Parvathaneni, et al.
Cell (2022) Vol. 185, Iss. 6, pp. 1008-1024.e15
Open Access | Times Cited: 145

Showing 1-25 of 145 citing articles:

mRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concern
Rishi R. Goel, Mark M. Painter, Sokratis A. Apostolidis, et al.
Science (2021) Vol. 374, Iss. 6572
Open Access | Times Cited: 804
Humoral and cellular immune memory to four COVID-19 vaccines
Zeli Zhang, José Mateus, Camila H. Coelho, et al.
Cell (2022) Vol. 185, Iss. 14, pp. 2434-2451.e17
Open Access | Times Cited: 466
Lipid nanoparticles enhance the efficacy of mRNA and protein subunit vaccines by inducing robust T follicular helper cell and humoral responses
Mohamad‐Gabriel Alameh, István Tombácz, Emily Bettini, et al.
Immunity (2021) Vol. 54, Iss. 12, pp. 2877-2892.e7
Open Access | Times Cited: 459
Immune imprinting, breadth of variant recognition, and germinal center response in human SARS-CoV-2 infection and vaccination
Katharina Röltgen, Sandra C. A. Nielsen, Oscar Silva, et al.
Cell (2022) Vol. 185, Iss. 6, pp. 1025-1040.e14
Open Access | Times Cited: 383
Correlates of protection against SARS‐CoV‐2 infection and COVID‐19 disease
David Goldblatt, Galit Alter, Shane Crotty, et al.
Immunological Reviews (2022) Vol. 310, Iss. 1, pp. 6-26
Open Access | Times Cited: 241
A multivalent nucleoside-modified mRNA vaccine against all known influenza virus subtypes
Claudia P. Arevalo, Marcus J. Bolton, Valerie Le Sage, et al.
Science (2022) Vol. 378, Iss. 6622, pp. 899-904
Open Access | Times Cited: 221
Immunological memory to SARS‐CoV ‐2 infection and COVID ‐19 vaccines
Alessandro Sette, Shane Crotty
Immunological Reviews (2022) Vol. 310, Iss. 1, pp. 27-46
Open Access | Times Cited: 216
Long-primed germinal centres with enduring affinity maturation and clonal migration
Jeong Hyun Lee, Henry J. Sutton, Christopher A. Cottrell, et al.
Nature (2022) Vol. 609, Iss. 7929, pp. 998-1004
Open Access | Times Cited: 125
T Cell Responses to SARS-CoV-2
Alessandro Sette, John Sidney, Shane Crotty
Annual Review of Immunology (2023) Vol. 41, Iss. 1, pp. 343-373
Closed Access | Times Cited: 122
Antibody-mediated neutralization of SARS-CoV-2
Henning Gruell, Kanika Vanshylla, Timm Weber, et al.
Immunity (2022) Vol. 55, Iss. 6, pp. 925-944
Open Access | Times Cited: 120
SARS-CoV-2 Omicron boosting induces de novo B cell response in humans
Wafaa B. Alsoussi, Sameer Kumar Malladi, Julian Q. Zhou, et al.
Nature (2023) Vol. 617, Iss. 7961, pp. 592-598
Open Access | Times Cited: 114
Memory B cells
Takeshi Inoue, Tomohiro Kurosaki
Nature reviews. Immunology (2023) Vol. 24, Iss. 1, pp. 5-17
Closed Access | Times Cited: 112
Persistent B cell memory after SARS-CoV-2 vaccination is functional during breakthrough infections
Sara Terreri, Eva Piano Mortari, M. Vinci, et al.
Cell Host & Microbe (2022) Vol. 30, Iss. 3, pp. 400-408.e4
Open Access | Times Cited: 104
SARS-CoV-2-specific T cells in the changing landscape of the COVID-19 pandemic
Antonio Bertoletti, Nina Le Bert, Anthony T. Tan
Immunity (2022) Vol. 55, Iss. 10, pp. 1764-1778
Open Access | Times Cited: 96
Prior vaccination promotes early activation of memory T cells and enhances immune responses during SARS-CoV-2 breakthrough infection
Mark M. Painter, Timothy S. Johnston, Kendall A. Lundgreen, et al.
Nature Immunology (2023) Vol. 24, Iss. 10, pp. 1711-1724
Open Access | Times Cited: 71
mRNA vaccines against SARS-CoV-2 induce comparably low long-term IgG Fc galactosylation and sialylation levels but increasing long-term IgG4 responses compared to an adenovirus-based vaccine
Jana Sophia Buhre, Tamás Pongrácz, Inga Künsting, et al.
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 68
Lipid nanoparticles (LNP) induce activation and maturation of antigen presenting cells in young and aged individuals
Jennifer Connors, David Joyner, Nathan Mege, et al.
Communications Biology (2023) Vol. 6, Iss. 1
Open Access | Times Cited: 59
Human circulating and tissue-resident memory CD8+ T cells
Marcus Buggert, David A. Price, Laura K. Mackay, et al.
Nature Immunology (2023) Vol. 24, Iss. 7, pp. 1076-1086
Open Access | Times Cited: 48
Development of an mRNA-lipid nanoparticle vaccine against Lyme disease
Matthew Pine, Gunjan Arora, Thomas Hart, et al.
Molecular Therapy (2023) Vol. 31, Iss. 9, pp. 2702-2714
Open Access | Times Cited: 46
Duration of SARS-CoV-2 mRNA vaccine persistence and factors associated with cardiac involvement in recently vaccinated patients
Aram J. Krauson, Faye Victoria C. Casimero, Zakir Siddiquee, et al.
npj Vaccines (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 46
The immunostimulatory nature of mRNA lipid nanoparticles
Preeti Sharma, Daniek Hoorn, Anjaiah Aitha, et al.
Advanced Drug Delivery Reviews (2024) Vol. 205, pp. 115175-115175
Open Access | Times Cited: 41
Human Cytomegalovirus mRNA-1647 Vaccine Candidate Elicits Potent and Broad Neutralization and Higher Antibody-Dependent Cellular Cytotoxicity Responses Than the gB/MF59 Vaccine
Xintao Hu, Krithika P. Karthigeyan, Savannah Herbek, et al.
The Journal of Infectious Diseases (2024) Vol. 230, Iss. 2, pp. 455-466
Closed Access | Times Cited: 27
Visualizing lipid nanoparticle trafficking for mRNA vaccine delivery in non-human primates
Maureen Buckley, Mariluz Araínga, Laura Maiorino, et al.
Molecular Therapy (2025) Vol. 33, Iss. 3, pp. 1105-1117
Open Access | Times Cited: 4
Linking vaccine adjuvant mechanisms of action to function
Elana Ben‐Akiva, Asheley P. Chapman, Tianyang Mao, et al.
Science Immunology (2025) Vol. 10, Iss. 104
Closed Access | Times Cited: 2
Infection or a third dose of mRNA vaccine elicits neutralizing antibody responses against SARS-CoV-2 in kidney transplant recipients
Xavier Charmetant, Maxime Espi, Iliès Benotmane, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 636
Open Access | Times Cited: 62
Page 1 - Next Page

Scroll to top